ALMANAC

From Wikipedia, the free encyclopedia
Revision as of 03:33, 30 July 2021 by imported>Citation bot (Alter: url. URLs might have been anonymized. | Use this bot. Report bugs. | Suggested by Abductive | Category:Oncology stubs | #UCB_Category 55/220)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Script error: No such module "about".

ALMANAC is a major breast cancer trial. The acronym stands for "Axillary Lymphatic Mapping Against Nodal Axillary Clearance." This major randomized trial performed in several centres in the UK produced clear evidence that sentinel node biopsy (SNB), used to stage axillary spread of disease, can be used with low failed localization and false negative rates, provided both radioisotope and blue dye are used to locate the sentinel nodes.[1]

References

Template:Reflist


Template:Asbox

  1. ↑ Script error: No such module "citation/CS1".
Retrieved from "http://debianws.lexgopc.com/wiki143/index.php?title=ALMANAC&oldid=1787761"